High prevalence of undiagnosed anxiety symptoms among HIV-positive individuals on cART: a cross-sectional study

B.M. Celesia, L. Nigro, M.R. Pinzone, C. Coco, R. La Rosa, F. Bisicchia, S. Mavilla, M. Gussio, G. Pellicanò, V. Milioni, F. Palermo, R. Russo, M.T. Mughini, F. Martellotta, R. Taibi, B. Cacopardo, G. Nunnari

Department of Clinical and Molecular Biomedicine, Division of Infectious Diseases, University of Catania, Catania, Italy. bmcelesia@tin.it

---

• Infectious Diseases

INTRODUCTION: Anxiety disorders are frequent in HIV-infected individuals, can pre-exist or occur during HIV infection. We evaluated with a self-reported questionnaire whether anxiety is related to HIV clinical status and therapeutic success in a cohort of HIV-positive subjects in Sicily.

PATIENTS AND METHODS: We enrolled 251 patients on combination antiretroviral therapy (cART) for at least six months; Self Rating Anxiety State SAS 054 was used to diagnose anxiety and a Z score ≥ 45 points was considered diagnostic.

RESULTS: 47% of patients were diagnosed with anxiety. Patients showing symptoms related to anxiety had experienced a high number of therapeutic switches (fourth line or more).

CONCLUSIONS: These data confirm a high prevalence of anxiety symptoms among subjects with HIV infection in Eastern Sicily. Physicians should be aware of the extent of the problem and should be able to adequately manage anxiety in the setting of HIV infection.

Free PDF Download